Baekgaard N. Incidence and location of deep vein thrombosis in the lower extremies: what do we know? Phlebolymphology. 2017;24:97–104.
Beckman MG, Hooper WC, Critchley SE, Ortel TL. Venous thromboembolism: a public health concern. Am J Prev Med. 2010;38(4 Suppl):S495-501.
Comerota AJ, Kearon C, Gu CS, Julian JA, Goldhaber SZ, Kahn SR, et al. Endovascular thrombus removal for acute Iliofemoral deep vein thrombosis. Circulation. 2019;139(9):1162–73.
Article PubMed PubMed Central Google Scholar
Huynh N, Fares WH, Brownson K, Brahmandam A, Lee AI, Dardik A, et al. Risk factors for presence and severity of pulmonary embolism in patients with deep venous thrombosis. J Vasc Surg Venous Lymphat Disord. 2018;6(1):7–12.
Obi A, Barnes GD. Continuing to advance the venous agenda: long-term insights from the CAVA trial. J Am Heart Assoc. 2021;10(11): e021659.
Article PubMed PubMed Central Google Scholar
Kearon C, Akl EA, Ornelas J, Blaivas A, Jimenez D, Bounameaux H, et al. Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report. Chest. 2016;149(2):315–52.
Dexter DKH, Shaikh A, Schor J, Annambhotla S, Zybulewski A. Safety and Effectiveness of Mechanical Thrombectomy From the Fully Enrolled Multicenter, Prospective CLOUT Registry. J Soc Cardiovasc Angiogr Interv. 2023;2(2): 100585.
Popuri RK, Vedantham S. The role of thrombolysis in the clinical management of deep vein thrombosis. Arterioscler Thromb Vasc Biol. 2011;31(3):479–84.
Article CAS PubMed PubMed Central Google Scholar
Enden T, Haig Y, Klow NE, Slagsvold CE, Sandvik L, Ghanima W, et al. Long-term outcome after additional catheter-directed thrombolysis versus standard treatment for acute iliofemoral deep vein thrombosis (the CaVenT study): a randomised controlled trial. Lancet. 2012;379(9810):31–8.
Haig Y, Enden T, Grotta O, Klow NE, Slagsvold CE, Ghanima W, et al. Post-thrombotic syndrome after catheter-directed thrombolysis for deep vein thrombosis (CaVenT): 5-year follow-up results of an open-label, randomised controlled trial. Lancet Haematol. 2016;3(2):e64-71.
Vedantham S, Goldhaber SZ, Julian JA, Kahn SR, Jaff MR, Cohen DJ, et al. Pharmacomechanical catheter-directed thrombolysis for deep-vein thrombosis. N Engl J Med. 2017;377(23):2240–52.
Article PubMed PubMed Central Google Scholar
Notten P, Ten Cate-Hoek AJ, Arnoldussen C, Strijkers RHW, de Smet A, Tick LW, et al. Ultrasound-accelerated catheter-directed thrombolysis versus anticoagulation for the prevention of post-thrombotic syndrome (CAVA): a single-blind, multicentre, randomised trial. Lancet Haematol. 2020;7(1):e40–9.
Enden T, Resch S, White C, Wik HS, Klow NE, Sandset PM. Cost-effectiveness of additional catheter-directed thrombolysis for deep vein thrombosis. J Thromb Haemost. 2013;11(6):1032–42.
Article CAS PubMed PubMed Central Google Scholar
Kearon C, Gu CS, Julian JA, Goldhaber SZ, Comerota AJ, Gornik HL, et al. Pharmacomechanical catheter-directed thrombolysis in acute femoral-popliteal deep vein thrombosis: analysis from a stratified randomized trial. Thromb Haemost. 2019;119(4):633–44.
Douketis JD, Crowther MA, Foster GA, Ginsberg JS. Does the location of thrombosis determine the risk of disease recurrence in patients with proximal deep vein thrombosis? Am J Med. 2001;110(7):515–9.
Article CAS PubMed Google Scholar
Kahn SR, Shrier I, Julian JA, Ducruet T, Arsenault L, Miron MJ, et al. Determinants and time course of the postthrombotic syndrome after acute deep venous thrombosis. Ann Intern Med. 2008;149(10):698–707.
Kahn SR, Julian JA, Kearon C, Gu CS, Cohen DJ, Magnuson EA, et al. Quality of life after pharmacomechanical catheter-directed thrombolysis for proximal deep venous thrombosis. J Vasc Surg Venous Lymphat Disord. 2020;8(1):8–23.
Article PubMed PubMed Central Google Scholar
Thukral S, Salter A, Lancia S, Kahn SR, Vedantham S. Predictors of clinical outcomes of pharmacomechanical catheter-directed thrombolysis for acute iliofemoral deep vein thrombosis: analysis of a multicenter randomized trial. J Vasc Interv Radiol. 2022;33(10):1161–70.
Notten P, de Smet A, Tick LW, van de Poel MHW, Wikkeling ORM, Vleming LJ, et al. CAVA (ultrasound-accelerated catheter-directed thrombolysis on preventing post-thrombotic syndrome) trial: long-term follow-up results. J Am Heart Assoc. 2021;10(11): e018973.
Article PubMed PubMed Central Google Scholar
Lichtenberg MKW, Stahlhoff S, Mlynczak K, Golicki D, Gagne P, Razavi MK, et al. Endovascular mechanical thrombectomy versus thrombolysis in patients with iliofemoral deep vein thrombosis - a systematic review and meta-analysis. Vasa. 2021;50(1):59–67.
Venous thromboembolic diseases: diagnosis, management and thrombophilia testing. NICE guideline. 2020. Available from: hhps://www.nice.org.uk/guidance/ng158
Kakkos SK, Gohel M, Baekgaard N, Bauersachs R, Bellmunt-Montoya S, Black SA, et al. Editor’s choice - european society for vascular surgery (ESVS) 2021 clinical practice guidelines on the management of venous thrombosis. Eur J Vasc Endovasc Surg. 2021;61(1):9–82.
Kearon C, Akl EA, Comerota AJ, Prandoni P, Bounameaux H, Goldhaber SZ, et al. Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of chest physicians evidence-based clinical practice guidelines. Chest. 2012;141(2 Suppl):e419S – e496.
Article CAS PubMed PubMed Central Google Scholar
Ortel TL, Neumann I, Ageno W, Beyth R, Clark NP, Cuker A, et al. American society of hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism. Blood Adv. 2020;4(19):4693–738.
Article CAS PubMed PubMed Central Google Scholar
Vedantham S, Desai KR, Weinberg I, Marston W, Winokur R, Patel S, et al. Society of interventional radiology position statement on the endovascular management of acute iliofemoral deep vein thrombosis. J Vasc Interv Radiol. 2023;34(2):284–99.
Engelberger RP, Spirk D, Willenberg T, Alatri A, Do DD, Baumgartner I, et al. Ultrasound-assisted versus conventional catheter-directed thrombolysis for acute iliofemoral deep vein thrombosis. Circ Cardiovasc Interv. 2015. https://doi.org/10.1161/CIRCINTERVENTIONS.114.002027.
Engelberger RP, Stuck A, Spirk D, Willenberg T, Haine A, Periard D, et al. Ultrasound-assisted versus conventional catheter-directed thrombolysis for acute iliofemoral deep vein thrombosis: 1-year follow-up data of a randomized-controlled trial. J Thromb Haemost. 2017;15(7):1351–60.
Article CAS PubMed Google Scholar
Vedantham S, Salter A, Lancia S, Lewis L, Thukral S, Kahn SR. Clinical Outcomes of a pharmacomechanical catheter-directed venous thrombolysis strategy that included rheolytic thrombectomy in a multicenter randomized trial. J Vasc Interv Radiol. 2021;32(9):1296–309.
Article PubMed PubMed Central Google Scholar
Dopheide JF, Sebastian T, Engelberger RP, Haine A, Kucher N. Early clinical outcomes of a novel rheolytic directional thrombectomy technique for patients with iliofemoral deep vein thrombosis. Vasa. 2018;47(1):56–62.
Gong M, Fu G, Liu Z, Zhou Y, Kong J, Zhao B, et al. Rheolytic thrombectomy using an AngioJet ZelanteDVT catheter or a solent omni catheter for patients with proximal vein thrombosis. Thromb J. 2023;21(1):25.
Article CAS PubMed PubMed Central Google Scholar
Rohr AM, Kuo WT. Single-session pharmacomechanical catheter-directed thrombolysis using the JETi thrombectomy device for acute iliofemoral deep vein thrombosis refractory to therapeutic anticoagulation. J Vasc Interv Radiol. 2019;30(10):1682–5.
Razavi C, Khalsa B, Openshaw L, Razavi MK. Single-session treatment of patients with symptomatic iliocaval and iliofemoral deep vein thrombosis: technical results of a prospective pilot study. J Vasc Interv Radiol. 2022;33(2):183–8.
留言 (0)